What is Joy Therapeutics?
Joy Therapeutics is a dedicated provider of specialized therapy services for children, focusing on areas such as Applied Behavior Analysis (ABA), child development psychology, and DIR Floortime. Founded by Dvora Phillip, the company champions a child-centered methodology to address a spectrum of developmental challenges, including emotional, behavioral, sensory, social, and communication issues. Operating from a state-of-the-art clinic and offering in-home services, Joy Therapeutics also emphasizes parent training to foster stronger parent-child dynamics. Their core mission is to effect meaningful positive changes in children's lives through precisely tailored therapeutic interventions.
How much funding has Joy Therapeutics raised?
Joy Therapeutics has raised a total of $18K across 1 funding round:
Debt
$18K
Debt (2021): $18K with participation from PPP
What's next for Joy Therapeutics?
Operating at a Series A/B growth stage, Joy Therapeutics' recent acquisition of moderate growth capital signals a strategic push towards scaling its operations and enhancing its service offerings. This investment is likely earmarked for expanding its clinical facilities, broadening its team of specialized therapists, and potentially developing new therapeutic programs or technological integrations to further support its child-centered approach. The company's focus on comprehensive care, encompassing direct therapy and parent empowerment, positions it for sustained impact and market leadership in pediatric therapeutic services.
See full Joy Therapeutics company page
